IRIS UniCatt

De Stefano, Valerio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.418
EU - Europa 6.450
AS - Asia 5.967
SA - Sud America 1.580
AF - Africa 183
OC - Oceania 25
Continente sconosciuto - Info sul continente non disponibili 10
Totale 21.633
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.165
SG - Singapore 3.081
DE - Germania 1.654
CN - Cina 1.400
BR - Brasile 1.292
SE - Svezia 1.178
IT - Italia 990
UA - Ucraina 488
FR - Francia 413
IE - Irlanda 360
GB - Regno Unito 342
VN - Vietnam 332
PL - Polonia 251
ID - Indonesia 250
IN - India 243
FI - Finlandia 242
RU - Federazione Russa 181
AR - Argentina 121
CA - Canada 110
MX - Messico 97
IQ - Iraq 85
HK - Hong Kong 79
TR - Turchia 73
AT - Austria 71
JP - Giappone 71
BD - Bangladesh 70
ES - Italia 45
NL - Olanda 45
ZA - Sudafrica 43
BE - Belgio 40
KR - Corea 40
EC - Ecuador 36
PK - Pakistan 36
CO - Colombia 30
SA - Arabia Saudita 29
VE - Venezuela 29
CI - Costa d'Avorio 28
CZ - Repubblica Ceca 23
IR - Iran 22
MA - Marocco 22
CL - Cile 21
AU - Australia 20
LT - Lituania 20
PY - Paraguay 18
UZ - Uzbekistan 18
KE - Kenya 17
AE - Emirati Arabi Uniti 16
DZ - Algeria 16
AZ - Azerbaigian 15
CH - Svizzera 15
TN - Tunisia 15
JO - Giordania 14
RO - Romania 14
PE - Perù 13
UY - Uruguay 12
EG - Egitto 11
IL - Israele 11
NP - Nepal 10
CR - Costa Rica 9
HU - Ungheria 9
OM - Oman 9
DO - Repubblica Dominicana 8
KZ - Kazakistan 8
PT - Portogallo 8
ET - Etiopia 7
MD - Moldavia 7
PH - Filippine 7
AL - Albania 6
BG - Bulgaria 6
BO - Bolivia 6
GR - Grecia 6
JM - Giamaica 6
LV - Lettonia 6
MY - Malesia 6
SN - Senegal 6
A2 - ???statistics.table.value.countryCode.A2??? 5
AM - Armenia 5
DK - Danimarca 5
EE - Estonia 5
NO - Norvegia 5
PA - Panama 5
TH - Thailandia 5
TW - Taiwan 5
BH - Bahrain 4
BY - Bielorussia 4
GT - Guatemala 4
HR - Croazia 4
KG - Kirghizistan 4
NG - Nigeria 4
BB - Barbados 3
HN - Honduras 3
LA - Repubblica Popolare Democratica del Laos 3
LB - Libano 3
NI - Nicaragua 3
RS - Serbia 3
XK - ???statistics.table.value.countryCode.XK??? 3
CG - Congo 2
EU - Europa 2
GA - Gabon 2
GE - Georgia 2
Totale 21.596
Salva come PNG Salva come JPEG
Città #
Singapore 1.400
Chandler 1.169
Ashburn 681
Dublin 352
Beijing 289
Jacksonville 277
San Mateo 277
Munich 254
Jakarta 222
Wilmington 212
Dallas 211
Warsaw 211
Los Angeles 209
New York 197
Nanjing 187
Rome 182
Boston 168
Ann Arbor 161
Cattolica 160
Milan 150
Fairfield 147
Dearborn 143
Hefei 131
Houston 122
Woodbridge 122
Moscow 104
Ho Chi Minh City 102
Princeton 100
São Paulo 99
Redmond 95
Hanoi 91
Marseille 91
Seattle 91
Lawrence 90
Chicago 87
Helsinki 83
Hong Kong 76
Frankfurt am Main 75
Redwood City 75
Nanchang 68
Hyderabad 63
Buffalo 55
The Dalles 52
Nürnberg 49
Nuremberg 45
Rio de Janeiro 45
Tokyo 45
Bremen 43
Boardman 41
Belo Horizonte 38
Kent 37
London 37
Norwalk 37
Brussels 36
Hebei 35
Seoul 35
Kunming 33
Mountain View 33
Vienna 33
Cambridge 31
Toronto 31
Orem 30
Santa Clara 30
University Park 30
Abidjan 28
Hangzhou 28
San Francisco 28
Tianjin 28
Zhengzhou 28
Baghdad 27
Brooklyn 27
Detroit 27
Florence 27
Shenyang 27
Düsseldorf 26
Lancaster 26
Montreal 26
Poplar 26
Pune 26
Washington 26
Jiaxing 25
Leawood 25
Turku 25
Izmir 24
Johannesburg 24
Mexico City 24
Paris 24
Dhaka 23
Guangzhou 23
Kraków 23
Changsha 22
Curitiba 22
Atlanta 21
Campinas 21
Porto Alegre 21
Roubaix 20
Da Nang 19
Lappeenranta 19
Shanghai 19
Phoenix 18
Totale 10.778
Salva come PNG Salva come JPEG
Nome #
Vitamin D deficiency and supplementation in patients with aggressive B-cell lymphomas treated with immunochemotherapy 321
Risk factors for venous thromboembolism in patients with lymphoma requiring hospitalization 315
Arterial and venous thrombosis in patients with monoclonal gammopathy of undetermined significance: incidence and risk factors in a cohort of 1491 patients. 308
PD-L1 expression in peripheral blood granulocytes at diagnosis as prognostic factor in classical Hodgkin lymphoma 262
Association of congenital protein C deficiency and latent myeloproliferative disease as cause of splanchnic venous thrombosis in a 34-year-old woman 247
Haemostatic alterations induced by treatment with asparaginases and clinical consequences 229
Venous Thromboembolism in Lymphoma: Risk Stratification and Antithrombotic Prophylaxis 216
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 199
Fondaparinux in pregnancy: Could it be a safe option? A review of the literature. 188
Risk factor and etiology analysis of ischemic stroke in young adult patients 182
A randomized, double-blind trial of three aspirin regimens to optimize antiplatelet therapy in essential thrombocythemia 178
Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases 171
Safety of granulocyte-colony-stimulating factor in acute myocardial infarction (the Rigenera study). 169
Impact of Radiotherapy on Pain Relief and Recalcification in Plasma Cell Neoplasms : Long-Term Experience. 169
Health Technology Assessment of genetic testing for susceptibility to Venous Thromboembolism in Italy 168
Allogeneic cord blood transfusions prevent fetal haemoglobin depletion in preterm neonates. Results of the CB-TrIP study 166
Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases 163
Splanchnic vein thrombosis and myeloproliferative neoplasms: molecular-driven diagnosis and long-term treatment 163
Efficacy of lenalidomide plus dexamethasone for POEMS syndrome relapsed after autologous peripheral stem-cell transplantation 161
Dose-Dependent Effect of Granulocyte Transfusions in Hematological Patients with Febrile Neutropenia 159
Progressive multifocal leukoencephalopathy in patients with follicular lymphoma treated with bendamustine plus rituximab followed by rituximab maintenance 159
A real-time integrated framework to support clinical decision making for covid-19 patients 159
A Case of Heparin Allergy With Good Tolerability to Fondaparinux During Pregnancy 156
Antithrombin III in full-term and pre-term newborn infants: three cases of neonatal diagnosis of AT III congenital defect 154
Progressive multifocal leukoencephalopathy in patients with follicular lymphoma treated with bendamustine plus rituximab followed by rituximab maintenance 151
Impact of radiotherapy on pain relief and recalcification in plasma cell neoplasms: long-term experience 149
Factor V deficiency in pregnancy complicated by Rh immunization and placenta previa. A case report and review of the literature 149
Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments 148
Bone marrow megakaryocytic activation predicts fibrotic evolution of Philadelphia-negative myeloproliferative neoplasms 147
A clinical-molecular prognostic model to predict survival in patients with post polycythemia vera and post essential thrombocythemia myelofibrosis 145
Venous thromboembolism in multiple myeloma 144
Anti CD20-based immunochemotherapy abolishes antibody response to Covid-19 mRNA vaccine in lymphoma patients vaccinated during active first line treatment 142
Safety and efficacy of ruxolitinib in splanchnic vein thrombosis associated with myeloproliferative neoplasms 141
The Aspirin Regimens in Essential Thrombocythemia (ARES) phase II randomized trial design: Implementation of the serum thromboxane B(2) assay as an evaluation tool of different aspirin dosing regimens in the clinical setting 141
Bisphosphonate therapy in multiple myeloma in preventing vertebral collapses: preliminary report 138
Influence of the JAK2 V617F mutation and inherited thrombophilia on the thrombotic risk among patients with essential thrombocythemia 137
Absence of the JAK2 exon 12 mutations in patients with splanchnic venous thrombosis and without overt myeloproliferative neoplasms 136
Prevalence of the JAK2 V617F mutation in patients with unprovoked venous thromboembolism of common sites and without overt myeloproliferative neoplasms 134
Hyperhomocysteinemia and prevalence of polymorphisms of homocysteine metabolism-related enzymes in patients with inflammatory bowel disease 133
Role of flow-cytometric immunophenotyping in prediction of BCR/ABL1 gene rearrangement in adult B-cell acute lymphoblastic leukemia 131
Postpartum hemorrhage 129
Invasive fungal infections in chronic lymphoproliferative disorders: a monocentric retrospective study 128
A Case of Heparin Allergy With Good Tolerability to Fondaparinux During Pregnancy. 127
Invasive fungal infections in chronic lymphoproliferative disorders: A monocentric retrospective study 127
Autoimmune hemolytic anemia with gel-based immunohematology tests: neural network analysis 126
In vitro Effect of Eltrombopag Alone and in Combination With Azacitidine on Megakaryopoiesis in Patients With Myelodysplastic Syndrome 126
Development and validation of an International Prognostic Score of thrombosis in World Health Organization-essential thrombocythemia (IPSET-thrombosis) 126
Alternate use of thrombopoietin receptor agonists in adult primary immune thrombocytopenia patients: A retrospective collaborative survey from Italian hematology centers 125
A STARD-compliant prediction model for diagnosing thrombotic microangiopathies 124
Treatment of primary plasma cell leukemia with high doses of cyclophosphamide, bortezomib, and dexamethasone followed by double autologous HSCT 124
Allogeneic Hemopoietic Stem Cell Transplantation for Myelofibrosis: 2021 124
Full donor chimerism after allogeneic hematopoietic stem cells transplant for myelofibrosis: The role of the conditioning regimen 124
JAK2 V617F mutational frequency in essential thrombocythemia associated with splanchnic or cerebral vein thrombosis 123
Prognostic Factors Associated With Progression of Smoldering Multiple Myeloma to Symptomatic Form 122
Prognostic significance of normalized FDG-PET parameters in patients with multiple myeloma undergoing induction chemotherapy and autologous hematopoietic stem cell transplantation: a retrospective single-center evaluation 121
The risk of symptomatic pulmonary embolism due to proximal deep venous thrombosis differs in patients with different types of inherited thrombophilia 120
Increased prevalence of the G20210A prothrombin gene variant in acute coronary syndromes without metabolic or acquired risk factors or with limited extent of disease 119
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 117
Enhancing lymphoma diagnosis on core needle biopsies: Integrating immunohistochemistry with flow cytometry 116
Comorbidity assessment to determine prognosis in older adult patients with classical Hodgkin lymphoma 115
Obstetric complications and pregnancy-related venous thromboembolism: The effect of low-molecular-weight heparin on their prevention in carriers of factor V Leiden or prothrombin G20210A mutation 114
The prognostic impact of monoclonal immune globulin and free light chain secretion in diffuse large B cell lymphoma (DLBCL) 114
Endothelial activation predicts disseminated intravascular coagulopathy, cytokine release syndrome and prognosis in patients treated with anti-CD19 CAR-T 113
Splanchnic vein thrombosis and myeloproliferative neoplasms: molecular-driven diagnosis and long-term treatment 113
High rate of recurrent venous thromboembolism in patients with myeloproliferative neoplasms and effect of prophylaxis with Vitamin K antagonists 113
Inherited thrombophilia: treatment during pregnancy. 111
In families with inherited thrombophilia the risk of venous thromboembolism is dependent on the clinical phenotype of the proband 111
Ineherited Thrombophilia: treatment during pregnancy 111
Factor V deficiency in pregnancy complicated by Rh immunization and placenta previa. A case report and review of the literature 110
Multiple Myeloma Treatment in Real-world Clinical Practice: Results of a Prospective, Multinational, Noninterventional Study 110
Invasive fungal infections in chronic lymphoproliferative disorders: a monocentric retrospective study 109
Full donor chimerism after allogeneic hematopoietic stem cells transplant for myelofibrosis: The role of the conditioning regimen 108
PD-L1 expression in peripheral blood granulocytes at diagnosis as prognostic factor in classical Hodgkin lymphoma 108
Role of flow-cytometric immunophenotyping in prediction of BCR/ABL1 gene rearrangement in adult B-cell acute lymphoblastic leukemia 107
Platelet indices and glucose control in type 1 and type 2 diabetes mellitus: A case-control study 106
Ultrasound-Doppler diagnosis of Budd-Chiari syndrome 104
Serological and Molecular Characterization of Hepatitis C Virus-Related Cryoglobulinemic Vasculitis in Patients without Cryoprecipitate 101
Hydroxyurea-related toxicity in 3,411 patients with Ph'-negative MPN 101
The Effects of Granulocyte Colony-Stimulating Factor in Patients with a Large Anterior Wall Acute Myocardial Infarction to Prevent Left Ventricular Remodeling: A 10-Year Follow-Up of the RIGENERA Study 101
Endothelial activation predicts disseminated intravascular coagulopathy, cytokine release syndrome and prognosis in patients treated with anti-CD19 CAR-T cells 100
Practice-relevant revision of IPSET-thrombosis based on 1019 patients with WHO-defined essential thrombocythemia 100
Improved Detection of Minimal Residual Disease by 11C-Methionine PET/CT in a Young Patient With Unusual Extramedullary Presentation of Recurrent Multiple Myeloma 100
The C807T/G873A polymorphism in the platelet glycoprotein Ia gene and the risk of acute coronary syndrome in the Italian population 99
Increased CD95 (Fas) and PD-1 expression in peripheral blood T lymphocytes in COVID-19 patients 99
Cerebral vein thrombosis in patients with Philadelphia-negative myeloproliferative neoplasms. An European Leukemia Net study 98
Dose-dependent effect of granulocyte transfusions in hematological patients with febrile neutropenia 97
Nutritional status and quality of life in adults undergoing allogeneic hematopoietic stem cell transplantation 97
Splanchnic vein thrombosis in myeloproliferative neoplasms: Risk factors for recurrences in a cohort of 181 patients 96
Pre-Exposure to Defibrotide Prevents Endothelial Cell Activation by Lipopolysaccharide: An Ingenuity Pathway Analysis 96
Coagulopathy in Patients with Low/Intermediate Risk Acute Promyelocytic Leukemia treated with First Line Arsenic Trioxide in Combination with All-Trans Retinoic Acid: A Monocentric Experience 95
IgD multiple myeloma a descriptive report of 17 cases: survival and response to therapy 95
Leukocytosis is a risk factor for recurrent arterial thrombosis in young patients with polycythemia vera and essential thrombocythemia 95
Testing for inherited thrombophilia and consequences for antithrombotic prophylaxis in patients with venous thromboembolism and their relatives. A review of the Guidelines from Scientific Societies and Working Groups 95
Myeloid sarcoma with megakaryoblastic differentiation mimicking a sellar tumor 95
Primary plasma cell leukemia: a retrospective multicenter study of 73 patients 94
Association of Platelet Thromboxane Inhibition by Low-Dose Aspirin With Platelet Count and Cytoreductive Therapy in Essential Thrombocythemia 94
Dose-dependent effect of granulocyte transfusions in hematological patients with febrile neutropenia 92
Remission of acquired von Willebrand syndrome in a patient with chronic lymphocytic leukemia treated with venetoclax 92
Evaluation of the prevalence of severe hyperhomocysteinemia in adult patients with thrombosis who underwent screening for thrombophilia 91
Improved Detection of Minimal Residual Disease by 11C-Methionine PET/CT in a Young Patient with Unusual Extramedullary Presentation of Recurrent Multiple Myeloma 91
Totale 13.567
Salva come PNG Salva come JPEG
Categoria #
all - tutte 101.106
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 101.106
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021730 0 0 0 0 0 75 137 29 145 47 271 26
2021/20221.674 130 103 25 76 100 29 24 259 81 108 320 419
2022/20233.370 509 476 294 484 206 378 178 226 368 91 110 50
2023/20241.742 74 506 57 78 77 234 107 96 32 60 188 233
2024/20254.006 98 135 275 122 337 114 217 215 638 392 766 697
2025/20265.938 1.528 320 761 1.125 1.830 374 0 0 0 0 0 0
Totale 21.936